CLINICAL_TRIALS
trial_result
· 2013-09-06
Clinical Trial Update: Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema [Phase 3]
Summary
A Phase 3 study evaluating the safety and tolerability of pegaptanib sodium in diabetic macular edema has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Anti- VGF Inhibitor, Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2013-09-06